Region Oestergoetland
Verified site
Linkoping, Sweden
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
The study focuses on adults with Immunoglobulin A Nephropathy, a kidney condition in which a protein called IgA builds up in the filtering units of the kidneys and can cause blood in the urine, swelling, and reduced kidney function. Participants receive the investigational medicine Povetacicept, which is administered by subcutaneous injection (a shot given under the skin) at a dose of 80 mg. The primary aim of the trial is to evaluate the long‑term safety and tolerability of this treatment.
During the study, participants attend regular visits where doctors check for any adverse events (side effects) and monitor laboratory tests and vital signs. Kidney health is followed using several measures: the amount of protein lost in the urine over a 24‑hour period, reported as the 24-hour urine protein/creatinine ratio, which indicates how much protein is leaking from the kidneys; the estimated glomerular filtration rate, a blood test that estimates how well the kidneys are filtering waste; and the level of a specific protein called galactose-deficient immunoglobulin A1. The study also looks for signs of clinical remission, defined as low protein in the urine, absence of hematuria (blood in the urine), and stable kidney function, as well as the prevention of progression to end-stage kidney disease. The trial proceeds without a comparison group, and participants continue receiving the medication for an extended period while their health is regularly assessed.
The trial runs in 7 steps – from screening to follow-up. Each step says what happens and what the team monitors.
5 criteria
4 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Linkoping, Sweden
Marseille, France
Nantes, France
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.